Sign in Subscribe
Nervous system diseases

Intensified Treatment of Tuberculous Meningitis Yields Promising Results

Strategic Insights

— 1 min read

Researchers have made significant progress in understanding the impact of intensified treatment on mortality, disability, and safety in adults with tuberculous meningitis (TBM). A systematic review and meta-analysis published in Open Forum Infectious Diseases found that using higher-dose first-line drugs or adding second-line drugs with good cerebrospinal fluid (CSF) penetration can improve outcomes. However, the researchers stress the importance of uniform case definitions and consistent endpoints to standardize data.

Key Takeaways:

  • The deadliest form of tuberculosis, TBM, remains a significant public health concern, with inadequate penetration of rifampicin and ethambutol into the brain and CSF contributing to mortality.
  • Intensified TBM treatment, which includes higher-dose first-line drugs or addition of second-line drugs with good CSF penetration, has shown promise in improving outcomes, including reduced mortality.
  • The systematic review and meta-analysis evaluated the impact of intensified TBM treatment on mortality, disability, and safety in adults, concluding that uniform case definitions and consistent endpoints are essential for standardizing data.
  • The researchers highlighted the importance of intensifying treatment with drugs that have good CSF penetration, such as linezolid therapy and rifampicin therapy.
  • The study, funded by the Wellcome Early Career, US National Institutes of Health, and US National Institute of Health Fogarty International Center, underscored the need for further research to improve treatment outcomes for TBM patients.
  • The study's authors, including James A. Seddon from Imperial College London, emphasized the importance of collaboration and knowledge-sharing to combat the spread of TBM.

Statistics:

  • According to the researchers, the mortality rate for TBM remains high, with inadequate penetration of rifampicin and ethambutol into the brain and CSF contributing to mortality.
  • Thestudy found that intensified TBM treatment can reduce mortality odds ratios (OR) by 50% compared to standard-of-care regimens.
  • The study's authors noted that uniform case definitions and consistent endpoints are essential to standardize data, with 73% of studies not reporting standard definitions and 41% not reporting consistent outcomes.

Sources:

  • Intensified Treatment of Tuberculous Meningitis in Adults: A Systematic Review and Meta-analysis. Open Forum Infectious Diseases, 2025;12(10).
  • NewsRx. Study Data from Imperial College London Update Understanding of Meningitis (Intensified Treatment of Tuberculous Meningitis in Adults: A Systematic Review and Meta-analysis). World Disease Weekly. October 21, 2025; p 137.

Read more